| Name | insulin like growth factor I |
|---|---|
| Synonyms | IBP1; MGF; IBP1; IGF 1; IGF IA; IGF IB; IGF1; IGFI… |
| Name | sodium fluoride |
|---|---|
| CAS | sodium fluoride (NaF) |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 16194044 | Okopien B, Krysiak R, Labuzek K, Herman ZS: [Anabolic therapy of osteoporosis] . Pol Merkur Lekarski. 2005 Jul;19(109):118-21. In the present study we describe in details sodium fluoride, 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), growth hormone, insulin-like growth factor I, and parathormone and its analogues, describing their mechanism of action and adverse effects. |
81(1,1,1,1) | Details |
| 16124390 | Okopien B, Krysiak R, Labuzek K, Herman ZS: [Anabolic therapy in osteoporosis--part 1] . Pol Merkur Lekarski. 2005 Jun;18(108):712-4. In the present study we describe in details sodium fluoride, 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), growth hormone, insulin-like growth factor I, and parathormone and its analogues, describing their mechanism of action and adverse effects. |
81(1,1,1,1) | Details |
| 9510097 | Yamaguchi M, Gao YH: Potent effect of zinc acexamate on bone components in the femoral-metaphyseal tissues of elderly female rats. Gen Pharmacol. 1998 Mar;30(3):423-7. The effect of zinc acexamate (10 [-5] M) on the increase of alkaline phosphatase activity in the metaphyseal tissues was remarkable as compared with that of insulin (10 [-8] M), (10 [-9] M), insulin-like growth factor-I (10 [-8] M), transforming growth factor-beta (10 [-10] M), sodium fluoride (10 [-3] M), dexamethasone (10 [-7] M) and -4; 10 [-5] M) with an effective concentration. 4. |
6(0,0,1,1) | Details |
| 14713283 | Pepene CE, Seck T, Diel I, Minne HW, Ziegler R, Pfeilschifter J: Influence of fluor salts, hormone replacement therapy and calcitonin on the concentration of insulin-like growth factor (IGF)-I, IGF-II and transforming growth factor-beta 1 in human iliac crest bone matrix from patients with primary osteoporosis. Eur J Endocrinol. 2004 Jan;150(1):81-91. |
1(0,0,0,1) | Details |
| 9437512 | Ammann P, Rizzoli R, Caverzasio J, Bonjour JP: potentiates the osteogenic effects of IGF-I in aged ovariectomized rats. Bone. 1998 Jan;22(1):39-43. However, has been shown to enhance the protein phosphorylation of various constituents of intracellular signaling cascades in osteoblastic cells following stimulation of growth factor receptors such as the insulin-like growth factor-I (IGF-I) receptor. Adult ovariectomized osteopenic rats were treated with sodium fluoride at a dose of 6 mg/kg per day in drinking water for 8 weeks in association with IGF-I either at a dose of 2 mg/kg per day, which is capable of increasing bone mass, or at a lower dose without detectable skeletal effects. |
1(0,0,0,1) | Details |
| 11238469 | Rosen CJ, Bilezikian JP: Clinical review 123: Anabolic therapy for osteoporosis. . J Clin Endocrinol Metab. 2001 Mar;86(3):957-64. GH, insulin-like growth factor I, the statins, and PTH will be reviewed. |
1(0,0,0,1) | Details |